Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: fillet (3), clean (268), prepare (1000)

DA_3+10

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA DA (3+10)–Cytarabine-Daunorubicin In-Patient Regimen Regimen • Acute Myeloid Leukaemia –
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/DA-3-10.pdf

DA_2+5

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA DA (2 + 5) – Cytarabine-Daunorubicin In-Patient Regimen Regimen • Acute Myeloid
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/DA-2-5.pdf

Cytarabine_2000_FludarabineIdarubicin_FLA-Ida

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (2000)-FLUDARABINE-IDARUBICIN (FLA-IDA) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (2000)-Fl
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine-2000-FludarabineIdarubicin-FLA-Ida.pdf

Cytarabine_1000_FludarabineIdarubicin_FLA-Ida

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (1000)-FLUDARABINE-IDARUBICIN (FLA-IDA) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (1000)-Fl
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine-1000-FludarabineIdarubicin-FLA-Ida.pdf

Thyroid Cabozantinib

Description: Chemotherapy Protocol THYROID CANCER Regimen CABOZANTINIB • Thyroid – Cabozantinib (140mg-capsules) Indication • Unresectable, locall
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Thyroid-Cabozantinib.pdf

Azathioprine for interstitial lung disease (ILD) - patient information

Description: This factsheet contains useful information about the medicine azathioprine.
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/Azathioprine-for-interstitial-lung-disease-ILD-patient-information.pdf

Procedure for bioimpedance using the Seca mBCA

Description: NIHR Southampton Biomedical Research Centre The NIHR Southampton Biomedical Research Centre (BRC) has a tight quality assurance system fo
Url: /Media/Southampton-Clinical-Research/Procedures/BRCProcedures/Procedure-for-bioimpedance-using-the-Seca-mBCA.pdf

Procedure for circumference measurements of children

Description: NIHR Southampton Biomedical Research Centre The NIHR Southampton Biomedical Research Centre (BRC) has a tight quality a
Url: /Media/Southampton-Clinical-Research/Procedures/BRCProcedures/Procedure-for-circumference-measurements-of-children.pdf

Clinical candour: The absence of spin

Description: Auto Generated Title On these pages I discuss the clinical law on which our nursing and medical staff rely when caring
Url: /HealthProfessionals/Clinical-law-updates/Clinical-candour-The-absence-of-spin.aspx

Appendix B - VZIG risk assessment and prescription form

Description: Varicella zoster Immunoglobulin for post-exposure prophylaxis (PEP)Please note that UHS Pharmacy will issue VZIG only when both RISK ASSESSMENT and PRESCRIP
Url: /Media/UHS-website-2019/Docs/Post-Exposure-Prophylaxis-Policy/AppendixB-VZIGRiskAssessmentandPrescriptionForm.pdf

341 to 350 of 363

Previous … 33 34 35 36 37 Next